4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
UroGen Pharma Ltd. (URGN) operates in the Biotechnology industry and is headquartered in Princeton, United States with about 298 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, URGN reported $110M in revenue and ($154M) in net income.
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers.
Interactive charts & full statements → Open the URGN valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $110M | $90M | $83M | $64M | — |
| Gross Profit | $97M | $82M | $73M | $57M | — |
| Operating Income (EBIT) | ($125M) | ($97M) | ($66M) | ($79M) | — |
| Net Income | ($154M) | ($127M) | ($102M) | ($110M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $51M | $38M | $28M | $24M | $20M | — |
| Gross Profit | $47M | $34M | $24M | $21M | $18M | — |
| Operating Income (EBIT) | ($20M) | ($19M) | ($27M) | ($41M) | ($37M) | — |
| Net Income | ($24M) | ($26M) | ($33M) | ($50M) | ($44M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $200M | $286M | $178M | $136M | — |
| Total Liabilities | $306M | $294M | $244M | $225M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive URGN viewer.
About TickerBase · Data methodology & sources